Research Topics
| J R LaporteSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility studyD Capella
Institut Català de Farmacologia, Universitat Autonoma de Barcelona, CSU Vall d Hebron, Spain
Eur J Clin Pharmacol 53:299-302. 1998..The design, methods and main limitations of this case-population surveillance approach are described...
Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agentsJoan Ramon Laporte
Department of Pharmacology, Therapeutics and Toxicology, Universitat Autonoma de Barcelona, Barcelona, Spain
Drug Saf 27:411-20. 2004..The aim of this study was to estimate the risk of upper gastrointestinal bleeding associated with NSAIDs and analgesics, with special emphasis on those agents that have been introduced in recent years...
Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control studyXavier Vidal
Department of Pharmacology, Therapeutics and Toxicology, Universitat Autonoma de Barcelona, Passeig Vall d Hebron 129 139, Barcelona, Spain
Drug Saf 31:159-68. 2008..We present the results related to the use of antidepressants by the degree of serotonin reuptake inhibition they induce, the selectivity at monoamine transporters and the dose...
Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosisL Ibanez
Clinical Pharmacology Service, Vall d Hebron University Hospital, Barcelona, Spain
Pharmacoepidemiol Drug Saf 17:224-8. 2008..The use of granulocyte colony-stimulating factor (G-CSF) in the treatment of non-chemotherapy drug- induced agranulocytosis is controversial. We aimed at assessing the effect of G-CSF on the duration of agranulocytosis...
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic reviewE Montane
Unitat d Assaigs Clínics i Farmacoepidemiologia, Servei de Farmacologia Clinica, Pg Vall d Hebron, no 119 129, Hospital Universitari Vall d Hebron, 08035 Barcelona, Spain
Neurology 63:1357-63. 2004..To assess the efficacy of oral drugs in the treatment of spasticity in patients with nonprogressive neurologic disease (NPND)...
Impact of analgesic drug-use guidelines for the management of postoperative pain: a drug utilization studyA Vallano
, Hospital Universitari Vail d'Hebron, Departament de Farmacologia, , WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Barcelona, Spain
Int J Clin Pharmacol Ther 41:165-70. 2003..Prescribers seemed more receptive to a change in drug rather than issues related to the correct dose regimen. More research is needed to assess how educational activities can improve the management of postoperative pain...
Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic reviewE Montane
Fundació Institut Català de Farmacologia and Servei de Farmacologia Clínica, Hospital Universitari Vall d Hebron, 08035, Barcelona, Spain
Eur J Clin Pharmacol 62:971-88. 2006..To assess analgesic drugs in the treatment of postoperative pain after traumatic and orthopaedic surgery (TOS)...
Risk of acute liver injury associated with the use of drugs: a multicentre population surveyM Sabate
Fundacio Institut Catala de Farmacologia, Universitat Autonoma de Barcelona, Hospital Vall d Hebron, Barcelona, Spain
Aliment Pharmacol Ther 25:1401-9. 2007..Acute liver injury of uncertain aetiology is often drug related and quantitative information about the associated risk is scarce...
Evaluation of cefonicid use in a general hospitalC Rodriguez
Service of Clinical Pharmacology, Universitat Autonoma de Barcelona, Spain
DICP 23:154-6. 1989..The use of cefonicid instead of cefuroxime was associated with 20 percent cost savings; however, this study shows that optimal antibiotic prescribing may produce much greater savings...
Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approachL Ibanez
Servei de Farmacologia Clinica, CS Vall d Hebron, Barcelona, Spain
Eur Heart J 12:639-41. 1991..A relevant risk was identified only for aprindine, of the order of two cases per 1000 patient-years. Our data suggest that the risk of agranulocytosis associated with aprindine is lower than previously found...
Medical speciality and pattern of medicines prescriptionA Vallano
, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Department of Pharmacology, Therapeutics and Toxicology, , Barcelona, Spain
Eur J Clin Pharmacol 60:725-30. 2004..This has important implications for priority setting in information, continuous education and research...
